-
1
-
-
0347357747
-
Implications of PET based molecular imaging on the current and future practice of medicine
-
Alavi A., Kung J.W., Zhuang H. Implications of PET based molecular imaging on the current and future practice of medicine. Semin. Nucl. Med. 2004, 34:56-69.
-
(2004)
Semin. Nucl. Med.
, vol.34
, pp. 56-69
-
-
Alavi, A.1
Kung, J.W.2
Zhuang, H.3
-
2
-
-
2842561598
-
Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndromes)
-
Alberini J-L., Belhocine T., Hustinx R., Daenen F., Rigo P. Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndromes). Nucl. Med. Commun. 2003, 24:1081-1086.
-
(2003)
Nucl. Med. Commun.
, vol.24
, pp. 1081-1086
-
-
Alberini, J.-L.1
Belhocine, T.2
Hustinx, R.3
Daenen, F.4
Rigo, P.5
-
3
-
-
33746049245
-
Role of nuclear medicine in the management of cutaneous malignant melanoma
-
Belhocine T.Z., Scott A.M., Even-Spair E., Urbain J-L., Essner R. Role of nuclear medicine in the management of cutaneous malignant melanoma. J. Nucl. Med. 2006, 47:957-967.
-
(2006)
J. Nucl. Med.
, vol.47
, pp. 957-967
-
-
Belhocine, T.Z.1
Scott, A.M.2
Even-spair, E.3
Urbain, J.-L.4
Essner, R.5
-
4
-
-
33646847015
-
18FDG PET in oncology: the best and the worst (Review)
-
18FDG PET in oncology: the best and the worst (Review). Int. J. Oncol. 2006, 28:1249-1261.
-
(2006)
Int. J. Oncol.
, vol.28
, pp. 1249-1261
-
-
Belhocine, T.1
Spaepen, K.2
Dusart, M.3
Castaigne, C.4
Muylle, K.5
Bourgeois, P.6
Bourgeois, D.7
Dierckx, L.8
Flamen, P.9
-
6
-
-
33749066984
-
18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer
-
Cascini G.L., Avallone A., Delrio P., Guida C., Tatangelo F., Marone P., Aloj L., De Martinis F., Comella P., Parisi V., Lastoria S. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J. Nucl. Med. 2006, 47:1241-1248.
-
(2006)
J. Nucl. Med.
, vol.47
, pp. 1241-1248
-
-
Cascini, G.L.1
Avallone, A.2
Delrio, P.3
Guida, C.4
Tatangelo, F.5
Marone, P.6
Aloj, L.7
De Martinis, F.8
Comella, P.9
Parisi, V.10
Lastoria, S.11
-
7
-
-
0037315245
-
Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT
-
Cohade C., Osman M., Pannu H.K., Wahl R.L. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J. Nucl. Med. 2003, 44:170-176.
-
(2003)
J. Nucl. Med.
, vol.44
, pp. 170-176
-
-
Cohade, C.1
Osman, M.2
Pannu, H.K.3
Wahl, R.L.4
-
8
-
-
0031967456
-
FDG PET for detection and therapy control of metastatic germ cell tumor
-
Cremerius U., Effert P.J., Adam G., et al. FDG PET for detection and therapy control of metastatic germ cell tumor. J. Nucl. Med. 1998, 39:815-822.
-
(1998)
J. Nucl. Med.
, vol.39
, pp. 815-822
-
-
Cremerius, U.1
Effert, P.J.2
Adam, G.3
-
9
-
-
0029355220
-
18FDG whole-body PET in differentiating thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 1311
-
Feine U., Lietzenmayer R., Hanke J.P., Wohrle H., Muller-Schauenburg W. 18FDG whole-body PET in differentiating thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 1311. Nuklearlmedizin 1995, 34:127-134.
-
(1995)
Nuklearlmedizin
, vol.34
, pp. 127-134
-
-
Feine, U.1
Lietzenmayer, R.2
Hanke, J.P.3
Wohrle, H.4
Muller-schauenburg, W.5
-
11
-
-
0036411742
-
Clinical trial design for target-based therapy
-
Fox E., Curt G.A., Balis F.M. Clinical trial design for target-based therapy. Oncologist 2002, 7:401-409.
-
(2002)
Oncologist
, vol.7
, pp. 401-409
-
-
Fox, E.1
Curt, G.A.2
Balis, F.M.3
-
12
-
-
0018166544
-
Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose
-
Gallagher B.M., Fowler J.S., Gutterson N.I., MacGregor R.R., Wan C.N., Wolf A.P. Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J. Nucl. Med. 1978, 19:1154-1161.
-
(1978)
J. Nucl. Med.
, vol.19
, pp. 1154-1161
-
-
Gallagher, B.M.1
Fowler, J.S.2
Gutterson, N.I.3
MacGregor, R.R.4
Wan, C.N.5
Wolf, A.P.6
-
14
-
-
0042242676
-
The glycolytic phenotype in carcinogenesis and tumor invasion
-
Gatenby R.A., Gawlinski E.T. The glycolytic phenotype in carcinogenesis and tumor invasion. Cancer. Res. 2003, 63:3847-3854.
-
(2003)
Cancer. Res.
, vol.63
, pp. 3847-3854
-
-
Gatenby, R.A.1
Gawlinski, E.T.2
-
15
-
-
2942642492
-
Posttherapy [18F] Fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome
-
Grigsby P.W., Siegel B.A., Dehdashti F., Rader J., Zoberi I. Posttherapy [18F] Fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J. Clin. Oncol. 2004, 22:2167-2171.
-
(2004)
J. Clin. Oncol.
, vol.22
, pp. 2167-2171
-
-
Grigsby, P.W.1
Siegel, B.A.2
Dehdashti, F.3
Rader, J.4
Zoberi, I.5
-
16
-
-
3142626455
-
Quantification in clinical fluorodeoxyglucose positron emission tomography
-
(Review)
-
Hallett W.A. Quantification in clinical fluorodeoxyglucose positron emission tomography. Nucl. Med. Commun. 2005, 25:647-650. (Review).
-
(2005)
Nucl. Med. Commun.
, vol.25
, pp. 647-650
-
-
Hallett, W.A.1
-
17
-
-
0022885139
-
Efficient stereospecific synthesis of no-carrier-added 2-18F-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
-
Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-18F-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 1986, 27:235-238.
-
(1986)
J. Nucl. Med.
, vol.27
, pp. 235-238
-
-
Hamacher, K.1
Coenen, H.H.2
Stocklin, G.3
-
18
-
-
0036384894
-
Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region
-
Hany T.F., Gharehpagagh E., Kamel E.M. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur. J. Nucl. Med. Mol. Imaging. 2002, 29:1393-1398.
-
(2002)
Eur. J. Nucl. Med. Mol. Imaging.
, vol.29
, pp. 1393-1398
-
-
Hany, T.F.1
Gharehpagagh, E.2
Kamel, E.M.3
-
19
-
-
0016374648
-
Transport of sugars in tumor cell membranes
-
Hatanaka M. Transport of sugars in tumor cell membranes. Biochem. Biophys. Acta. 1974, 355:77-104.
-
(1974)
Biochem. Biophys. Acta.
, vol.355
, pp. 77-104
-
-
Hatanaka, M.1
-
20
-
-
28444469710
-
Very early detection of response to imatinib mesylate therapy of gastroinstestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography
-
Heinicke T., Wardelmann E., Sauerbruch T., et al. Very early detection of response to imatinib mesylate therapy of gastroinstestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography. Anticancer. Res. 2005, 25:4591-4594.
-
(2005)
Anticancer. Res.
, vol.25
, pp. 4591-4594
-
-
Heinicke, T.1
Wardelmann, E.2
Sauerbruch, T.3
-
21
-
-
0034909182
-
Pattern of uptake and excretion of (18)F-FDG in the lactating breast
-
Hicks R.J., Binns D., Stabin M.G. Pattern of uptake and excretion of (18)F-FDG in the lactating breast. J. Nucl. Med. 2001, 42:1238-1242.
-
(2001)
J. Nucl. Med.
, vol.42
, pp. 1238-1242
-
-
Hicks, R.J.1
Binns, D.2
Stabin, M.G.3
-
22
-
-
33845363671
-
18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference
-
18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann. Oncol. 2006, 17:1761-1765.
-
(2006)
Ann. Oncol.
, vol.17
, pp. 1761-1765
-
-
Hoffmann, M.1
Wohrer, S.2
Becherer, A.3
Chott, A.4
Streubel, B.5
Kletter, K.6
Raderer, M.7
-
23
-
-
0032879180
-
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
-
Hustinx R., Smith R.J., Benard F., et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur. J. Nucl. Med. 1999, 26:1345-1348.
-
(1999)
Eur. J. Nucl. Med.
, vol.26
, pp. 1345-1348
-
-
Hustinx, R.1
Smith, R.J.2
Benard, F.3
-
24
-
-
33746444445
-
Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET
-
Jackson R.S., Schlarman T.C., Hubble W.L., Osman M.M. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J. Nucl. Med. Technol. 2006, 34:29-33.
-
(2006)
J. Nucl. Med. Technol.
, vol.34
, pp. 29-33
-
-
Jackson, R.S.1
Schlarman, T.C.2
Hubble, W.L.3
Osman, M.M.4
-
25
-
-
0038646711
-
PET scan imaging in oncology
-
Jerusalem G., Hustinx R., Beguin Y., Fillet G. PET scan imaging in oncology. Eur. J. Cancer 2003, 39:1525-1534.
-
(2003)
Eur. J. Cancer
, vol.39
, pp. 1525-1534
-
-
Jerusalem, G.1
Hustinx, R.2
Beguin, Y.3
Fillet, G.4
-
26
-
-
0034948354
-
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's Lymphoma (NHL)
-
Jerusalem G., Beguin Y., Najjar F., et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's Lymphoma (NHL). Ann. Oncol. 2001, 12:825-830.
-
(2001)
Ann. Oncol.
, vol.12
, pp. 825-830
-
-
Jerusalem, G.1
Beguin, Y.2
Najjar, F.3
-
27
-
-
33745278885
-
Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization
-
Kaneta T., Hakamatsuka T., Takanami K., et al. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann. Nucl. Med. 2006, 20:203-208.
-
(2006)
Ann. Nucl. Med.
, vol.20
, pp. 203-208
-
-
Kaneta, T.1
Hakamatsuka, T.2
Takanami, K.3
-
28
-
-
0033255382
-
Visualization of normal organs in whole-body FDG-PET imaging
-
Kato F., Tsukamoto E., Suginami Y., et al. Visualization of normal organs in whole-body FDG-PET imaging. Kaku. Igaku. 1999, 36:971-977.
-
(1999)
Kaku. Igaku.
, vol.36
, pp. 971-977
-
-
Kato, F.1
Tsukamoto, E.2
Suginami, Y.3
-
29
-
-
0026539682
-
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography
-
Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 1992, 33:1972-1980.
-
(1992)
J. Nucl. Med.
, vol.33
, pp. 1972-1980
-
-
Kubota, R.1
Yamada, S.2
Kubota, K.3
Ishiwata, K.4
Tamahashi, N.5
Ido, T.6
-
30
-
-
33644817639
-
Potential of dual time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET
-
Kumar R., Loving V.A., Chauhan A., Zhuang H., Mitchell S., Alavi A. Potential of dual time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J. Nucl. Med. 2005, 46:1819-1824.
-
(2005)
J. Nucl. Med.
, vol.46
, pp. 1819-1824
-
-
Kumar, R.1
Loving, V.A.2
Chauhan, A.3
Zhuang, H.4
Mitchell, S.5
Alavi, A.6
-
31
-
-
0029927549
-
FDG-PET screening for cerebral metastases in patients with suspected malignancy
-
Larcos G., Maisey M.N. FDG-PET screening for cerebral metastases in patients with suspected malignancy. Nucl. Med. Commun. 1996, 17:197-198.
-
(1996)
Nucl. Med. Commun.
, vol.17
, pp. 197-198
-
-
Larcos, G.1
Maisey, M.N.2
-
32
-
-
1542399591
-
18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT
-
18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J. Nucl. Med. 2004, 45:266-271.
-
(2004)
J. Nucl. Med.
, vol.45
, pp. 266-271
-
-
Lerman, H.1
Metser, U.2
Grisaru, D.3
-
33
-
-
0027505656
-
Influence of the blood glucose concentration on FDG uptake in cancer-a PET study
-
Lindholm P., Minn H., Leskinen-Kallio S. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J. Nucl. Med. 1993, 34:1-6.
-
(1993)
J. Nucl. Med.
, vol.34
, pp. 1-6
-
-
Lindholm, P.1
Minn, H.2
Leskinen-kallio, S.3
-
34
-
-
0036452450
-
Overview of clinical PET
-
Maisey M.N. Overview of clinical PET. Br. J. Radiol. 2002, 75:S1-S5.
-
(2002)
Br. J. Radiol.
, vol.75
-
-
Maisey, M.N.1
-
35
-
-
0029121996
-
Simultaneous emission and transmission measurements for attenuation correction in whole-body PET
-
Meikle S.R., Bailey D.L., Hooper P.K., Eberl S., Hutton B.F., Jones W.F., Fulton R.R., Fulham M.J. Simultaneous emission and transmission measurements for attenuation correction in whole-body PET. J. Nucl. Med. 1995, 36:1680-1688.
-
(1995)
J. Nucl. Med.
, vol.36
, pp. 1680-1688
-
-
Meikle, S.R.1
Bailey, D.L.2
Hooper, P.K.3
Eberl, S.4
Hutton, B.F.5
Jones, W.F.6
Fulton, R.R.7
Fulham, M.J.8
-
36
-
-
0026801196
-
Type 1 glucose transporter from the mouse which are responsive to serum, growth factors, and oncogenes
-
Mukarami T., Nishiyama T., Shirotani T., et al. Type 1 glucose transporter from the mouse which are responsive to serum, growth factors, and oncogenes. J. Biol. Chem. 1992, 267:9300-9306.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 9300-9306
-
-
Mukarami, T.1
Nishiyama, T.2
Shirotani, T.3
-
37
-
-
0031971927
-
FDG accumulation and tumor biology
-
Pauwels E.K.J., Ribeiro M.J., Stoot J.H.M.B., McCready V.R., Bourguigon M., Mazière B. FDG accumulation and tumor biology. Nuclear. Med. Biol. 1998, 25:317-322.
-
(1998)
Nuclear. Med. Biol.
, vol.25
, pp. 317-322
-
-
Pauwels, E.K.J.1
Ribeiro, M.J.2
Stoot, J.H.M.B.3
McCready, V.R.4
Bourguigon, M.5
Mazière, B.6
-
38
-
-
0034241796
-
Inaugural article: positron emission tomography provides molecular imaging of biological processes
-
Phelps M.E. Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:9226-9233.
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 9226-9233
-
-
Phelps, M.E.1
-
39
-
-
0344603857
-
Long-distance transport of radionuclides between PET cyclotron and PET radiochemistry
-
Preusche S., Fuchtner F., Steinbach J., Zessin J., Krug H., Neumann W. Long-distance transport of radionuclides between PET cyclotron and PET radiochemistry. Appl. Radiat. Isot. 1999, 51:625-630.
-
(1999)
Appl. Radiat. Isot.
, vol.51
, pp. 625-630
-
-
Preusche, S.1
Fuchtner, F.2
Steinbach, J.3
Zessin, J.4
Krug, H.5
Neumann, W.6
-
40
-
-
0032080718
-
Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients
-
Rinne D., Baum R.P., Hor G., Kaufman R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer 1998, 82:1664-1671.
-
(1998)
Cancer
, vol.82
, pp. 1664-1671
-
-
Rinne, D.1
Baum, R.P.2
Hor, G.3
Kaufman, R.4
-
41
-
-
0032616268
-
Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants
-
Shreve P.D., Anzai Y., Wahl R.L. Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999, 19:61-77.
-
(1999)
Radiographics
, vol.19
, pp. 61-77
-
-
Shreve, P.D.1
Anzai, Y.2
Wahl, R.L.3
-
42
-
-
0032616268
-
Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants
-
Shreve P.D., Anzai Y., Wahl R.L. Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999, 19:150-151.
-
(1999)
Radiographics
, vol.19
, pp. 150-151
-
-
Shreve, P.D.1
Anzai, Y.2
Wahl, R.L.3
-
43
-
-
0037569527
-
FDG PET monitoring of tumour response to chemotherapy: does (18F)FDG uptake correlate with the viable tumour cell fraction?
-
Spaepen K., Stroobants S., Dupont P., et al. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does (18F)FDG uptake correlate with the viable tumour cell fraction?. Eur. J. Nucl. Med. Mol. Imag. 2003, 30:682-688.
-
(2003)
Eur. J. Nucl. Med. Mol. Imag.
, vol.30
, pp. 682-688
-
-
Spaepen, K.1
Stroobants, S.2
Dupont, P.3
-
44
-
-
0025845450
-
The applications of PET in clinical oncology
-
Strauss L.G., Conti P.S. The applications of PET in clinical oncology. J. Nucl. Med. 1991, 32:801-820.
-
(1991)
J. Nucl. Med.
, vol.32
, pp. 801-820
-
-
Strauss, L.G.1
Conti, P.S.2
-
45
-
-
0016441373
-
A positron-emission transaxial tomograph for nuclear imaging (PETT)
-
Ter-Pogossian M.M., Phelps M.E., Hoffman E.J., Mullani N.A. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology 1975, 114:89-98.
-
(1975)
Radiology
, vol.114
, pp. 89-98
-
-
Ter-pogossian, M.M.1
Phelps, M.E.2
Hoffman, E.J.3
Mullani, N.A.4
-
46
-
-
0032110744
-
A new look at the cyclotron for making short-lived isotopes. 1966-classical article
-
Ter-Pogossian M.M., Wagner H.N. A new look at the cyclotron for making short-lived isotopes. 1966-classical article. Sem. Nucl. Med. 1998, 28:202-212.
-
(1998)
Sem. Nucl. Med.
, vol.28
, pp. 202-212
-
-
Ter-pogossian, M.M.1
Wagner, H.N.2
-
47
-
-
0032888251
-
Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group
-
Vansteenkiste J.F., Stroobants S.G., Dupont P.J., et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J. Clin. Oncol. 1999, 17:3201-3206.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 3201-3206
-
-
Vansteenkiste, J.F.1
Stroobants, S.G.2
Dupont, P.J.3
-
48
-
-
0026939275
-
Positron emission tomography at the turn of the century: a perspective
-
Wagner H.N. Positron emission tomography at the turn of the century: a perspective. Semin. Nucl. Med. 1991, 22:285-288.
-
(1991)
Semin. Nucl. Med.
, vol.22
, pp. 285-288
-
-
Wagner, H.N.1
-
50
-
-
0032757213
-
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group
-
Young H., Baum R., Cremerius U., et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur. J. Cancer 1999, 35:1773-1782.
-
(1999)
Eur. J. Cancer
, vol.35
, pp. 1773-1782
-
-
Young, H.1
Baum, R.2
Cremerius, U.3
-
51
-
-
0035106073
-
F-18 FDG uptake in the large arteries: a new observation
-
Yun M., Yeh D., Araujo Li, Jang S., Newberg A., Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin. Nucl. Med. 2001, 26:314-319.
-
(2001)
Clin. Nucl. Med.
, vol.26
, pp. 314-319
-
-
Yun, M.1
Yeh, D.2
Araujo, L.3
Jang, S.4
Newberg, A.5
Alavi, A.6
|